Cargando…
Impact of Testosterone Therapy on Hematocrit and Polycythemia: Evaluation of Data From Two Ongoing Open-Label Randomized Single-Center Clinical Trials
Introduction & Objective: Testosterone (T) replacement therapy (TRT) is the mainstay treatment for male hypogonadism. The most commonly reported adverse event among men using TRT is polycythemia. What is unknown is whether the short-acting vs. long-acting testosterone preparations have different...
Autores principales: | Gonzalez, Daniel, Kresch, Eliyahu, Ory, Jesse, Nackeeran, Sirpi, Blachman-Braun, Ruben, Molina, Manuel, Ramasamy, Ranjith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090421/ http://dx.doi.org/10.1210/jendso/bvab048.1544 |
Ejemplares similares
-
Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021) -
Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023) -
Advanced Paternal Age and Sperm DNA Fragmentation: A Systematic Review
por: Gonzalez, Daniel C., et al.
Publicado: (2022) -
Is tadalafil associated with decreased risk of major adverse cardiac events or venous thromboembolism in men with lower urinary tract symptoms?
por: Goberdhan, Sankalp, et al.
Publicado: (2022) -
Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials
por: Diaz, Parris, et al.
Publicado: (2023)